Back to search results

COMMETS- Combination MCI Metabolic Syndrome

IsraelRecruitingPHASE2

Conditions

Alzheimer Disease · Mild Cognitive Impairment · Metabolic Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Joseph Sagol Neuroscience center, Sheba Medical Center, Ramat Gan, Israel

    Contact: Study coordinator (Iscka Yore, BS.c.) · Iscka.Yore@sheba.health.gov.il · 03-5305439
    Contact: Principal Investigator (michal beeri, Prof)
Study leads

  • Tal Davidy

    Study Director

    Sheba Medical Center

  • Michal Schnaider beeri

    Principal Investigator

    Rutgers, The State University of New Jersey

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)